Posted on 01/14/2018 4:21:10 AM PST by grundle
When Ivana Hollan, MD, came to Harvard Medical School and Brigham and Women’s Hospital in October 2015 as a visiting scientist, it was more than just a tremendous professional opportunity. For the rheumatologist, who is living with myeloma, traveling 3,500 miles from her Norway home to the Longwood Medical Area also put her next door to Dana-Farber – and close to cancer care that the Norwegian government has refused to pursue or insure due to its high cost.
For this and other reasons, Hollan extended her academic appointments and began ongoing treatment at Dana-Farber’s Jerome Lipper Multiple Myeloma Center.
Despite the obvious benefits, including being cared for by hematologist/oncologist Paul Richardson, MD, who is making remarkable inroads against the disease, it was not an easy decision. Hollan’s husband, son, and daughter live in Norway, but she knows that returning home could compromise her health.
“Everybody talks about how wonderful Norway’s health care is, and that was my experience until I needed medical treatment for my cancer,” says Hollan, 52. “I never imagined that the government would not be willing to support new oncology drugs and treatments. It’s sad to be away from my family, but here I am cared for by an incredible team that treats me like family – in a beautiful healing environment that doesn’t look or feel like a hospital. It has helped me put aside my sadness and look to the future.”
Hollan was not eligible for treatment in Norway because the government run health care providers there felt the state-of-the-art drugs needed for her care were too expensive. At Dana-Farber, after her disease progressed following initial systemic therapy and maintenance, Richardson offered her an immunotherapy-based clinical trial in August 2016 that has stabilized her disease for the past year, and which she has tolerated moderately well.
Hollan’s story has made headlines back home, where she and others are pressuring the Norwegian government to reconsider its stance on costly experimental treatments like immunotherapy. The combination of drugs she is on at Dana-Farber are approved for use by the Federal Drug Administration in the United States and by the European Medicines Agency for public hospitals in several European countries – but are near-impossible to get in Norway.
“Novel therapies have made substantial improvements in patient outcomes in myeloma globally during the last decade-plus, and the greatest clinical benefit has been seen in the United States – where access to new treatments has been the best,” says Richardson. “Nationally, the prognosis for overall patient survival has gone from 3-5 years to 7-10, and in our practice we are seeing some patients survive 20 years or more from diagnosis with active disease. This constitutes remarkable progress and hope, and it is truly our privilege to offer this kind of therapeutic opportunity to Ivana.”
Hollan splits her weeks between work and treatment, with high praise for the total patient care she receives at Dana-Farber. She loves being greeted at the Yawkey Center by the sounds of a volunteer pianist or harpist and receiving acupuncture in the Leonard P. Zakim Center for Integrative Therapies and Healthy Living.
One important advocate is tracking much of her journey: Her daughter, Barbora, a student at the Norwegian Film Institute, is training to be a documentarian and has made Ivana’s cancer experience a college project. For six weeks this summer and fall, she stayed with Ivana in Boston and recorded her mother’s day-to-day experiences.
“The driving motive behind the movie, and what pushes it forward, is the political fight, but it’s also about how much fun you can still have while living with cancer,” says Barbora Hollan. “I was worried it would be emotionally hard on me, but it’s been great to see the whole picture of my mother’s life. I’ve found it difficult keeping up with her.” This optimism is why Ivana has a response for Richardson’s initial prognosis. “He expects me to live to 80,” she says. “Why not 85?”
I thought socialized medicine was wonderful and the Norwegians were the happiest people in the world.
Except for the ones still pining for the fjords.
But if she were muslim?
“I thought socialized medicine was wonderful and the Norwegians were the happiest people in the world.”
Just another reason why I would not want to live anywhere BUT THE UNITED STATES OF AMERICA. I am so thankful that I was born in America. This should give everyone pause to think of our wonderful country.
“I thought socialized medicine was wonderful and the Norwegians were the happiest people in the world.”
Just another reason why I would not want to live anywhere BUT THE UNITED STATES OF AMERICA. I am so thankful that I was born in America. This should give everyone pause to think of our wonderful country.
So who DID pay for the treatment? And how much did it cost?
But real medical care ?
America is such a great country...Norway...
I look at socialist vs. free market health care coverage as analogous to veterinary medicine for livestock vs. pets. Ranchers want the biggest bang for the buck, so they invest in preventatives like vaccines, but spend very little if an animal develops a more serious disorder. Pet owners, OTOH, care less about the expense and more about a positive outcome, so they are willing to spend much more than the rancher on care for individual animals.
That is socialized medicine: go all out on the minor stuff, but set limits on spending on serious diseases.
I'm sure it take decades of research and FDA approval costing, on average, nearly a billion dollars to bring any new drug to market. I see the article states she is in an immunotherapy study so I'm guessing that Capitalism is funding this. Venture capitalists buy stocks in bioresearch firms. They then short and use options to manage their risks as the majority of studies will fail to achieve good results.
Socialist systems are not capable of doing this type of cutting edge research. However, I have heard some people say that Europeans are the FDA's favorite lab rat.
Thanx !
Has she overstayed her visa? How is she here legally?
Norwegian Blue…lovely plumage
Norway stop complaining to us, complain to the EU,
for all the good it will do you.
It says she is a working MD in the article. At least she makes some contribution to her care I imagine unlike the invaders who get it all free on the taxpayers.
what kind of talk is that??
This woman sounds like another liberal who got mugged, this time by socialized medicine. Wonder if her entire world view has been changed, or just a “woe is me” because of the specific medical situation and its effect on her entire life.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.